Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

Antimicrobial Agents and Chemotherapy Minireviews

View Other ASM Journals Minireviews: Minireview Collection

From the Current Issue: November 2009; volume 53, issue 11 [Table of Contents]

VanA-Type Vancomycin-Resistant Staphylococcus aureus

Bruno Perichon and Patrice Courvalin
Antimicrob. Agents Chemother. 2009. 53:4580-4587. [Abstract] [HTML] [PDF]

From Past Issues:

Molecular Basis and Phenotype of Methicillin Resistance in Staphylococcus aureus and Insights into New β-Lactams That Meet the Challenge

Leticia I. Llarrull, Jed F. Fisher, and Shahriar Mobashery
Antimicrob. Agents Chemother. 2009. 53:4051-4063. [HTML] [PDF]

Antiretroviral Drug Resistance in Human Immunodeficiency Virus Type 2

Michel L. Ntemgwa, Thomas d'Aquin Toni, Bluma G. Brenner, Ricardo J. Camacho, and Mark A. Wainberg
Antimicrob. Agents Chemother. 2009. 53:3611-3619. [HTML] [PDF]

A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance

G. E. Louw, R. M. Warren, N. C. Gey van Pittius, C. R. E. McEvoy, P. D. Van Helden, and T. C. Victor
Antimicrob. Agents Chemother. 2009. 53:3181-3189. [HTML] [PDF]

Resistance Plasmid Families in Enterobacteriaceae

Alessandra Carattoli
Antimicrob. Agents Chemother. 2009. 53:2227-2238. [HTML] [PDF]

New Drugs against Tuberculosis: Problems, Progress, and Evaluation of Agents in Clinical Development

Jossy van den Boogaard, Gibson S. Kibiki, Elton R. Kisanga, Martin J. Boeree, and Rob E. Aarnoutse
Antimicrob. Agents Chemother. 2009. 53:849-862. [HTML] [PDF]

Genetic Elements Responsible for Erythromycin Resistance in Streptococci

Pietro E. Varaldo, Maria Pia Montanari, and Eleonora Giovanetti
Antimicrob. Agents Chemother. 2009. 53:343-353. [HTML] [PDF]

Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications

David Andes, Andres Pascual, and Oscar Marchetti
Antimicrob. Agents Chemother. 2009. 53:24-34. [HTML] [PDF]

A Practical Guide to Measuring Mutation Rates in Antibiotic Resistance

Cassie F. Pope, Denise M. O'Sullivan, Timothy D. McHugh, and Stephen H. Gillespie
Antimicrob. Agents Chemother. 2008. 52:1209-1214. [HTML] [PDF]

Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli

Christian G. Giske, Dominique L. Monnet, Otto Cars, Yehuda Carmeli, and on behalf of ReAct-Action on Antibiotic Resistance
Antimicrob. Agents Chemother. 2008. 52:813-821. [HTML] [PDF]

Quinolone-Mediated Bacterial Death

Karl Drlica, Muhammad Malik, Robert J. Kerns, and Xilin Zhao
Antimicrob. Agents Chemother. 2008. 52:385-392. [HTML] [PDF]

Interpretation of Antibiotic Concentration Ratios Measured in Epithelial Lining Fluid

Sungmin Kiem and Jerome J. Schentag
Antimicrob. Agents Chemother. 2008. 52:24-36. [HTML] [PDF]

Outbreaks Associated with Contaminated Antiseptics and Disinfectants

David J. Weber, William A. Rutala, and Emily E. Sickbert-Bennett
Antimicrob. Agents Chemother. 2007. 51:4217-4224. [HTML] [PDF]

Global Challenge of Multidrug-Resistant Acinetobacter baumannii

Federico Perez, Andrea M. Hujer, Kristine M. Hujer, Brooke K. Decker, Philip N. Rather, and Robert A. Bonomo
Antimicrob. Agents Chemother. 2007. 51:3471-3484. [HTML] [PDF]

Impact of Melanin on Microbial Virulence and Clinical Resistance to Antimicrobial Compounds

Joshua D. Nosanchuk and Arturo Casadevall
Antimicrob. Agents Chemother. 2006. 50:3519-3528. [HTML] [PDF]

Resistance of Yersinia pestis to Antimicrobial Agents

Marc Galimand, Elisabeth Carniel, and Patrice Courvalin
Antimicrob. Agents Chemother. 2006. 50:3233-3236. [HTML] [PDF]

ß-Lactamase Nomenclature

George A. Jacoby
Antimicrob. Agents Chemother. 2006. 50:1123-1129. [HTML] [PDF]

Quinolones for Treatment of Human Brucellosis: Critical Review of the Evidence from Microbiological and Clinical Studies

Matthew E. Falagas and Ioannis A. Bliziotis
Antimicrob. Agents Chemother. 2006. 50:22-33. [HTML] [PDF]

Prospects for Aminoacyl-tRNA Synthetase Inhibitors as New Antimicrobial Agents

Julian Gregston Hurdle, Alexander John O'Neill, and Ian Chopra
Antimicrob. Agents Chemother. 2005. 49:4821-4833. [HTML] [PDF]

From the Th1/Th2 Paradigm towards a Toll-Like Receptor/T-Helper Bias

Mihai G. Netea, Jos W. M. Van der Meer, Roger P. Sutmuller, Gosse J. Adema, and Bart-Jan Kullberg
Antimicrob. Agents Chemother. 2005. 49:3991-3996. [HTML] [PDF]

Insertions in the Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Genes: Clinical Impact and Molecular Mechanisms

Mark A. Winters and Thomas C. Merigan
Antimicrob. Agents Chemother. 2005. 49:2575-2582. [HTML] [PDF]

New Small-Molecule Synthetic Antimycobacterials

Lluis Ballell, Robert A. Field, Ken Duncan, and Robert J. Young
Antimicrob. Agents Chemother. 2005. 49:2153-2163. [HTML] [PDF]

Changing Patterns in the Selection of Viral Mutations among Patients Receiving Nucleoside and Nucleotide Drug Combinations Directed against Human Immunodeficiency Virus Type 1 Reverse Transcriptase

Mark A. Wainberg, Bluma G. Brenner, and Dan Turner
Antimicrob. Agents Chemother. 2005. 49:1671-1678. [HTML] [PDF]

Molecular Detection of the Macrolide Efflux Gene: To Discriminate or Not To Discriminate between mef(A) and mef(E)

Corne H. W. Klaassen and Johan W. Mouton
Antimicrob. Agents Chemother. 2005. 49:1271-1278. [HTML] [PDF]

Human Cytomegalovirus Resistance to Antiviral Drugs

C. Gilbert and G. Boivin
Antimicrob. Agents Chemother. 2005. 49:873-883. [HTML] [PDF]

Aminoglycoside Resistance in Pseudomonas aeruginosa

Keith Poole
Antimicrob. Agents Chemother. 2005. 49:479-487. [HTML] [PDF]

Vancomycin Resistance in Enterococci Due to Synthesis of Precursors Terminating in D-Alanyl-D-Serine

Peter E. Reynolds and Patrice Courvalin
Antimicrob. Agents Chemother. 2005. 49:21-25. [HTML] [PDF]

Chloroquine Resistance in Plasmodium vivax

J. Kevin Baird
Antimicrob. Agents Chemother. 2004. 48:4075-4083. [HTML] [PDF]

Antimicrobial Peptides from Marine Invertebrates

J. Andy Tincu and Steven W. Taylor
Antimicrob. Agents Chemother. 2004. 48:3645-3654. [HTML] [PDF]

In Vitro Analyses, Animal Models, and 60 Clinical Cases of Invasive Aspergillus terreus Infection

William J. Steinbach, John R. Perfect, Wiley A. Schell, Thomas J. Walsh, and Daniel K. Benjamin Jr.
Antimicrob. Agents Chemother. 2004. 48:3217-3225. [HTML] [PDF]

Hazard Ratio in Clinical Trials

Spotswood L. Spruance, Julia E. Reid, Michael Grace, and Matthew Samore
Antimicrob. Agents Chemother. 2004. 48:2787-2792. [HTML] [PDF]

Recommendations for Treatment of Human Infections Caused by Bartonella Species

J. M. Rolain, P. Brouqui, J. E. Koehler, C. Maguina, M. J. Dolan, and D. Raoult
Antimicrob. Agents Chemother. 2004. 48:1921-1933. [HTML] [PDF]

Issues in Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents: Distribution in Tissue

Markus Muller, Amparo dela Pena, and Hartmut Derendorf
Antimicrob. Agents Chemother. 2004. 48:1441-1453. [HTML] [PDF]

P Glycoprotein in Human Immunodeficiency Virus Type 1 Infection and Therapy

Sanjay U. C. Sankatsing, Jos H. Beijnen, Alfred H. Schinkel, Joep M. A. Lange, and Jan M. Prins
Antimicrob. Agents Chemother. 2004. 48:1073-1081. [HTML] [PDF]

Combination Antifungal Therapy

Melissa D. Johnson, Conan MacDougall, Luis Ostrosky-Zeichner, John R. Perfect, and John H. Rex
Antimicrob. Agents Chemother. 2004. 48:693-715. [HTML] [PDF]

Issues in Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents: Kill Curves versus MIC

Markus Mueller, Amparo de la Pena, and Hartmut Derendorf
Antimicrob. Agents Chemother. 2004. 48:369-377. [HTML] [PDF]

Growing Group of Extended-Spectrum ß-Lactamases: the CTX-M Enzymes

R. Bonnet
Antimicrob. Agents Chemother. 2004. 48:1-14. [HTML] [PDF]

Ribosomal Protection Proteins and Their Mechanism of Tetracycline Resistance

Sean R. Connell, Dobryan M. Tracz, Knud H. Nierhaus, and Diane E. Taylor
Antimicrob. Agents Chemother. 2003. 47:3675-3681. [HTML] [PDF]

Molecular Impact of the M184V Mutation in Human Immunodeficiency Virus Type 1 Reverse Transcriptase

Karidia Diallo, Matthias Gotte, and M. A. Wainberg
Antimicrob. Agents Chemother. 2003. 47:3377-3383. [HTML] [PDF]

Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic Methods

Catherine Liu and Henry F. Chambers
Antimicrob. Agents Chemother. 2003. 47:3040-3045. [HTML] [PDF]

Ambler Class A Extended-Spectrum ß-Lactamases in Pseudomonas aeruginosa: Novel Developments and Clinical Impact

Gerhard F. Weldhagen, Laurent Poirel, and Patrice Nordmann
Antimicrob. Agents Chemother. 2003. 47:2385-2392. [HTML] [PDF]

Combination Chemotherapy of Schistosomiasis in Laboratory Studies and Clinical Trials

Jurg Utzinger, Jennifer Keiser, Xiao Shuhua, Marcel Tanner, and Burton H. Singer
Antimicrob. Agents Chemother. 2003. 47:1487-1495. [HTML] [PDF]

In Vivo Pharmacodynamics of Antifungal Drugs in Treatment of Candidiasis

David Andes
Antimicrob. Agents Chemother. 2003. 47:1179-1186. [HTML] [PDF]

FemABX Peptidyl Transferases: a Link between Branched-Chain Cell Wall Peptide Formation and ß-Lactam Resistance in Gram-Positive Cocci

S. Rohrer and B. Berger-Bachi
Antimicrob. Agents Chemother. 2003. 47:837-846. [HTML] [PDF]

Resistance to Macrolides and Related Antibiotics in Streptococcus pneumoniae

Roland Leclercq and Patrice Courvalin
Antimicrob. Agents Chemother. 2002. 46:2727-2734. [HTML] [PDF]

Clindamycin as an Antimalarial Drug: Review of Clinical Trials

Bertrand Lell and Peter G. Kremsner
Antimicrob. Agents Chemother. 2002. 46:2315-2320. [HTML] [PDF]

Effects of Antibiotics on Nosocomial Epidemiology of Vancomycin-Resistant Enterococci

Stephan Harbarth, Sara Cosgrove, and Yehuda Carmeli
Antimicrob. Agents Chemother. 2002. 46:1619-1628. [HTML] [PDF]

Antiparasitic Agent Atovaquone

Aaron L. Baggish and David R. Hill
Antimicrob. Agents Chemother. 2002. 46:1163-1173. [HTML] [PDF]

Evolution of Drug Resistance in Mycobacterium tuberculosis: Clinical and Molecular Perspective

Stephen H. Gillespie
Antimicrob. Agents Chemother. 2002. 46:267-274. [HTML] [PDF]

Plasmid-Determined AmpC-Type ß-Lactamases

Alain Philippon, Guillaume Arlet, and George A. Jacoby
Antimicrob. Agents Chemother. 2002. 46:1-11. [HTML] [PDF]

Use of Aminoglycosides in Treatment of Infections Due to Intracellular Bacteria

M. Maurin and D. Raoult
Antimicrob. Agents Chemother. 2001. 45:2977-2986. [HTML] [PDF]

Clinical and Experimental Advances in Treatment of Visceral Leishmaniasis

Henry W. Murray
Antimicrob. Agents Chemother. 2001. 45:2185-2197. [HTML] [PDF]

Riddle of Biofilm Resistance

Kim Lewis
Antimicrob. Agents Chemother. 2001. 45:999-1007. [HTML] [PDF]

Bacteriophage Therapy

Alexander Sulakvelidze, Zemphira Alavidze, and J. Glenn Morris Jr.
Antimicrob. Agents Chemother. 2001. 45:649-659. [HTML] [PDF]

Regulation of VanA- and VanB-Type Glycopeptide Resistance in Enterococci

Michel Arthur and Richard Quintiliani Jr.
Antimicrob. Agents Chemother. 2001. 45:375-381. [HTML] [PDF]

Macrolide Resistance Conferred by Base Substitutions in 23S rRNA

Birte Vester and Stephen Douthwaite
Antimicrob. Agents Chemother. 2001. 45:1-12. [HTML] [PDF]

Aminoglycosides: Perspectives on Mechanisms of Action and Resistance and Strategies to Counter Resistance

Lakshmi P. Kotra, Jalal Haddad, and Shahriar Mobashery
Antimicrob. Agents Chemother. 2000. 44:3249-3256. [HTML] [PDF]

A Neutrophil-Derived Anti-Infective Molecule: Bactericidal/Permeability-Increasing Protein

Ofer Levy
Antimicrob. Agents Chemother. 2000. 44:2925-2931. [HTML] [PDF]

Efflux-Mediated Resistance to Fluoroquinolones in Gram-Positive Bacteria and the Mycobacteria

Keith Poole
Antimicrob. Agents Chemother. 2000. 44:2595-2599. [HTML] [PDF]

Efflux-Mediated Resistance to Fluoroquinolones in Gram-Negative Bacteria

Keith Poole
Antimicrob. Agents Chemother. 2000. 44:2233-2241. [HTML] [PDF]

Impact of Antimicrobial Agents and Chemotherapy from 1972 to 1998

Morton N. Swartz
Antimicrob. Agents Chemother. 2000. 44:2009-2016. [HTML] [PDF]

Mutation Frequencies and Antibiotic Resistance

J. L. Martinez and F. Baquero
Antimicrob. Agents Chemother. 2000. 44:1771-1777. [HTML] [PDF]

Nomenclature for Macrolide and Macrolide-Lincosamide-Streptogramin B Resistance Determinants

Marilyn C. Roberts, Joyce Sutcliffe, Patrice Courvalin, Lars Bogo Jensen, Julian Rood, and Helena Seppala
Antimicrob. Agents Chemother. 1999. 43:2823-2830. [HTML] [PDF]

Lack of Cell Wall Peptidoglycan versus Penicillin Sensitivity: New Insights into the Chlamydial Anomaly

Jean-Marie Ghuysen and Colette Goffin
Antimicrob. Agents Chemother. 1999. 43:2339-2344. [HTML] [PDF]

Antibiotic Resistance in Listeria spp.

Emmanuelle Charpentier and Patrice Courvalin
Antimicrob. Agents Chemother. 1999. 43:2103-2108. [HTML] [PDF]

Antiretroviral-Drug Concentrations in Semen: Implications for Sexual Transmission of Human Immunodeficiency Virus Type 1

Angela D. M. Kashuba, John R. Dyer, Linda M. Kramer, Ralph H. Raasch, Joseph J. Eron, and Myron S. Cohen
Antimicrob. Agents Chemother. 1999. 43:1817-1826. [HTML] [PDF]

Why Metronidazole Is Active against both Bacteria and Parasites

John Samuelson
Antimicrob. Agents Chemother. 1999. 43:1533-1541. [HTML] [PDF]

Peptide Antibiotics

Robert E.?W. Hancock and Daniel S. Chapple
Antimicrob. Agents Chemother. 1999. 43:1317-1323. [HTML] [PDF]

History of Antimicrobial Agents and Chemotherapy from 1972 to 1998

George A. Jacoby
Antimicrob. Agents Chemother. 1999. 43:999-1002. [HTML] [PDF]

Aminoglycosides: Nephrotoxicity

Marie-Paule Mingeot-Leclercq and Paul M. Tulkens
Antimicrob. Agents Chemother. 1999. 43:1003-1012. [HTML] [PDF]

Aminoglycosides: Activity and Resistance

Marie-Paule Mingeot-Leclercq, Youri Glupczynski, and Paul M. Tulkens
Antimicrob. Agents Chemother. 1999. 43:727-737. [HTML] [PDF]

Genomics and Antimicrobial Drug Discovery

Donald T. Moir, Karen J. Shaw, Roberta S. Hare, and Gerald F. Vovis
Antimicrob. Agents Chemother. 1999. 43:439-446. [HTML] [PDF]

Genetic Methods for Assessing Antimicrobial Resistance

Franklin R. Cockerill III
Antimicrob. Agents Chemother. 1999. 43:199-212. [HTML] [PDF]

Antifungal Peptides: Novel Therapeutic Compounds against Emerging Pathogens

Anthony J. De Lucca and Thomas J. Walsh
Antimicrob. Agents Chemother. 1999. 43:1-11. [HTML] [PDF]

Resistance to Human Immunodeficiency Virus Type 1 Protease Inhibitors

Daniel Boden and Martin Markowitz
Antimicrob. Agents Chemother. 1998. 42:2775-2783. [HTML] [PDF]

Tn916 Family Conjugative Transposons and Dissemination of Antimicrobial Resistance Determinants

Louis B. Rice
Antimicrob. Agents Chemother. 1998. 42:1871-1877. [HTML] [PDF]

Two-Component Signal Transduction as a Target for Microbial Anti-Infective Therapy

John F. Barrett and James A. Hoch
Antimicrob. Agents Chemother. 1998. 42:1529-1536. [HTML] [PDF]

Treatment of Infection Due to Pneumocystis carinii

Jay Alan Fishman
Antimicrob. Agents Chemother. 1998. 42:1309-1314. [HTML] [PDF]

Prevention of Infection Due to Pneumocystis carinii

Jay Alan Fishman
Antimicrob. Agents Chemother. 1998. 42:995-1004. [HTML] [PDF]

Kinship and Diversification of Bacterial Penicillin-Binding Proteins and -Lactamases

Irina Massova and Shahriar Mobashery
Antimicrob. Agents Chemother. 1998. 42:1-17. [HTML] [PDF]

Why are antibiotic resistance genes so resistant to elimination?

AA Salyers and CF Amabile-Cuevas
Antimicrob. Agents Chemother. 1997. 41:2321-2325. [PDF]

Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon

MN Alekshun and SB Levy
Antimicrob. Agents Chemother. 1997. 41:2067-2075. [PDF]

Assessment of the pharmacodynamic properties of antimalarial drugs in vivo

NJ White
Antimicrob. Agents Chemother. 1997. 41:1413-1422. [PDF]

The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics

I Chopra, J Hodgson, B Metcalf, and G Poste
Antimicrob. Agents Chemother. 1997. 41:497-503. [PDF]

Carbapenem-hydrolyzing beta-lactamases

BA Rasmussen and K Bush
Antimicrob. Agents Chemother. 1997. 41:223-232. [PDF]

O-Acetyltransferases for chloramphenicol and other natural products

IA Murray and WV Shaw
Antimicrob. Agents Chemother. 1997. 41:1-6. [PDF]

Antibiotic-impregnated cement and beads for orthopedic infections

DA Wininger and RJ Fass
Antimicrob. Agents Chemother. 1996. 40:2675-2679. [PDF]

Susceptibility testing of Mycobacterium avium complex isolates

L Heifets
Antimicrob. Agents Chemother. 1996. 40:1759-1767. [PDF]

Fungal virulence genes as targets for antifungal chemotherapy

JR Perfect
Antimicrob. Agents Chemother. 1996. 40:1577-1583. [Abstract] [PDF]

Synthetic combinatorial libraries: novel discovery strategy for identification of antimicrobial agents

SE Blondelle, E Perez-Paya, and RA Houghten
Antimicrob. Agents Chemother. 1996. 40:1067-1071. [PDF]

Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription

EJ Arts and MA Wainberg
Antimicrob. Agents Chemother. 1996. 40:527-540. [PDF]

Antifungal agents: chemotherapeutic targets and immunologic strategies

NH Georgopapadakou and TJ Walsh
Antimicrob. Agents Chemother. 1996. 40:279-291. [PDF]

Tetracycline resistance mediated by ribosomal protection

DE Taylor and A Chau
Antimicrob. Agents Chemother. 1996. 40:1-5. [PDF]

Antimicrobial properties of tea (Camellia sinensis L.)

JM Hamilton-Miller
Antimicrob. Agents Chemother. 1995. 39:2375-2377. [PDF]

Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae

MM Paris, O Ramilo, and GH McCracken Jr
Antimicrob. Agents Chemother. 1995. 39:2171-2175. [PDF]

Use of amphotericin B with azole antifungal drugs: what are we doing?

AM Sugar
Antimicrob. Agents Chemother. 1995. 39:1907-1912. [PDF]

Beige mouse model for Mycobacterium avium complex disease

PR Gangadharam
Antimicrob. Agents Chemother. 1995. 39:1647-1654. [PDF]

Antifungal agents in neonatal systemic candidiasis

JN van den Anker, NM van Popele, and PJ Sauer
Antimicrob. Agents Chemother. 1995. 39:1391-1397. [PDF]

A functional classification scheme for beta-lactamases and its correlation with molecular structure

K Bush, GA Jacoby, and AA Medeiros
Antimicrob. Agents Chemother. 1995. 39:1211-1233. [PDF]

Antiviral activities of isometric dideoxynucleosides of D- and L- related stereochemistry

V Nair and TS Jahnke
Antimicrob. Agents Chemother. 1995. 39:1017-1029. [Abstract] [PDF]

Insights into erythromycin action from studies of its activity as inducer of resistance

B Weisblum
Antimicrob. Agents Chemother. 1995. 39:797-805. [PDF]

Erythromycin resistance by ribosome modification

B Weisblum
Antimicrob. Agents Chemother. 1995. 39:577-585. [PDF]

Trimethoprim and sulfonamide resistance

P Huovinen, L Sundstrom, G Swedberg, and O Skold
Antimicrob. Agents Chemother. 1995. 39:279-289. [PDF]

Resistance of Candida species to fluconazole

JH Rex, MG Rinaldi, and MA Pfaller
Antimicrob. Agents Chemother. 1995. 39:1-8. [PDF]